Kunal Potnis, MD
DownloadHi-Res Photo
About
Titles
Hospital Resident
Education & Training
- MD
- Yale School of Medicine (2023)
- BS
- Duke University (2017)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Kunal Potnis's published research.
Publications Timeline
A big-picture view of Kunal Potnis's research output by year.
Ilana Richman, MD, MHS
Scott Huntington, MD, MPH, MSc
Cary Gross, MD
Francine Foss, MD
George Goshua, MD, MSc, FACP
Harlan Krumholz, MD, SM
8Publications
49Citations
Publications
2023
Cost‐effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States
Potnis K, Viswanathan G, Bona R, Ito S, Kempton C, Pandya A, Krumholz H, Goshua G. Cost‐effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United States. American Journal Of Hematology 2023, 98: e247-e250. PMID: 37401660, DOI: 10.1002/ajh.27014.Peer-Reviewed Original ResearchAltmetricBalancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
Potnis K, Huntington S. Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma. Blood Advances 2023, 7: 2573-2574. PMID: 36745098, PMCID: PMC10242627, DOI: 10.1182/bloodadvances.2023009864.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsCost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Potnis K, Di M, Isufi I, Gowda L, Seropian S, Foss F, Forman H, Huntington S. Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma. Blood Advances 2023, 7: 801-810. PMID: 36342852, PMCID: PMC10011202, DOI: 10.1182/bloodadvances.2022008097.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCAR T-cell therapyT-cell therapyQuality-adjusted life yearsIncremental cost-effectiveness ratioCAR T cellsChimeric antigen receptor T-cell therapySOC therapyFollicular lymphomaT cellsLife yearsR FLRefractory follicular lymphomaT cell strategiesThird-line settingLines of therapyIncremental clinical benefitUS payer perspectiveCost-effectiveness ratioTherapy remissionUnselected patientsCare therapyClinical benefitClinical trialsTreatment strategiesPayer perspective
2022
Artificial Intelligence in Breast Cancer Screening
Potnis K, Ross J, Aneja S, Gross C, Richman I. Artificial Intelligence in Breast Cancer Screening. JAMA Internal Medicine 2022, 182: 1306-1312. PMID: 36342705, PMCID: PMC10623674, DOI: 10.1001/jamainternmed.2022.4969.Peer-Reviewed Original ResearchCitationsAltmetricWhen competition is not enough: leveraging US policies to curb oral anticancer drug costs
Potnis KC, Huntington SF. When competition is not enough: leveraging US policies to curb oral anticancer drug costs. The Lancet Oncology 2022, 23: 836-837. PMID: 35772451, DOI: 10.1016/s1470-2045(22)00297-2.Commentaries, Editorials and LettersAltmetric
2020
Industry Payments and New Breast Cancer Screening Technology Use
Potnis KC, Gross CP, Richman IB. Industry Payments and New Breast Cancer Screening Technology Use. Journal Of General Internal Medicine 2020, 36: 1440-1442. PMID: 32468434, DOI: 10.1007/s11606-020-05771-9.Peer-Reviewed Original ResearchAltmetric
2019
Bone manifestations in neuronopathic Gaucher disease while receiving high-dose enzyme replacement therapy.
Potnis KC, Flueckinger LB, Ha CI, Upadia J, Frush DP, Kishnani PS. Bone manifestations in neuronopathic Gaucher disease while receiving high-dose enzyme replacement therapy. Mol Genet Metab 2019, 126: 157-161. PMID: 30448006, DOI: 10.1016/j.ymgme.2018.11.004.Peer-Reviewed Case Reports and Technical Notes
2018
Corticobasal syndrome in a man with Gaucher disease type 1: Expansion of the understanding of the neurological spectrum.
Potnis KC, Flueckinger LB, DeArmey SM, Alcalay RN, Cooney JW, Kishnani PS. Corticobasal syndrome in a man with Gaucher disease type 1: Expansion of the understanding of the neurological spectrum. Mol Genet Metab Rep 2018, 17: 69-72. PMID: 30364808, DOI: 10.1016/j.ymgmr.2018.10.001.Peer-Reviewed Case Reports and Technical Notes